title: Catheter ablation of ventricular tachycardia using radiofrequency current.
abstract: Catheter ablation techniques have evolved as an alternative to map-guided surgery and proven effective in a variety of supraventricular tachyarrhythmias. Direct current catheter ablation has been shown to be effective in about 50 to 70% of cases. Approximately, 60% of patients with structural heart disease and monomorphic ventricular tachycardia were successfully treated using direct current ablation techniques. This overall success rate and possible risks associated with the use of direct current have stimulated the search for other energy sources appropriate for catheter ablation. Presently, only a few preliminary reports on the clinical efficacy of radiofrequency energy for the treatment of ventricular tachyarrhythmias in man exist. 23 patients with identifiable heart disease at a mean age of 52 +/- 17 years underwent radiofrequency catheter ablation. 16 patients had coronary artery disease, one patient dilative cardiomyopathy and six patients had arrhythmogenic right ventricular disease. All patients presented with chronic current sustained ventricular tachycardia. After detailed endocardial catheter mapping radiofrequency energy was applied at the site of earliest ventricular activation during ventricular tachycardia which could be entrained during fixed rate ventricular pacing at the site of origin of ventricular tachycardia. At all ablation sites a long latency between the stimulus and QRS complex was noted. Of 23 patients 18 were treated with radiofrequency alone whereas in five patients a second ablation procedure using direct current was performed. Following the ablation procedures, 14 patients (61%) remained free of ventricular tachycardia. One patient died due to congestive heart failure 21 months following ablation.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Hospital of the Westfälische Wilhelms-University of Münster, Department of Cardiology and Angiology, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Borggrefe
authors.forename: S
authors.initials: S
authors.lastname: Willems
authors.forename: X
authors.initials: X
authors.lastname: Chen
authors.forename: G
authors.initials: G
authors.lastname: Hindricks
authors.forename: W
authors.initials: W
authors.lastname: Haverkamp
authors.forename: A
authors.initials: A
authors.lastname: Martinez-Rubio
authors.forename: C
authors.initials: C
authors.lastname: Hief
authors.forename: M
authors.initials: M
authors.lastname: Shenasa
authors.forename: G
authors.initials: G
authors.lastname: Breithardt
mesh_terms: D006328:Cardiac Catheterization / Q000295:instrumentation*; D002423:Cause of Death; D004562:Electrocardiography; D004564:Electrocoagulation / Q000295:instrumentation*; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000503:physiopathology / Q000601:surgery; D006352:Heart Ventricles / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D011183:Postoperative Complications / Q000401:mortality; D013610:Tachycardia / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*